Breast Cancer: Recurrent Genomic Alterations: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Adding multiple tables |
Adding original reference |
||
| Line 1: | Line 1: | ||
'''Table 1 - Clinically significant copy number alterations in breast cancer''' | '''Table 1 - Clinically significant copy number alterations in breast cancer''' Table derived from Geiersbach et al., 2018 [<nowiki>PMID 32087595</nowiki>] with permission from Cancer Genetics. | ||
{| class="wikitable" | {| class="wikitable" | ||
|'''Alteration''' | |'''Alteration''' | ||
| Line 71: | Line 71: | ||
|METABRIC IntClust1, ER Positive | |METABRIC IntClust1, ER Positive | ||
|} | |} | ||
'''Table 2 - Major clinically significant genes associated with somatic sequence alterations in breast cancer''' | '''Table 2 - Major clinically significant genes associated with somatic sequence alterations in breast cancer''' Table derived from Geiersbach et al., 2018 [<nowiki>PMID 32087595</nowiki>] with permission from Cancer Genetics. | ||
{| class="wikitable" | {| class="wikitable" | ||
|'''Gene(s)''' | |'''Gene(s)''' | ||
| Line 253: | Line 253: | ||
|Benign or likely benign | |Benign or likely benign | ||
|} | |} | ||
'''Table 3 - Genes with known hereditary risk associations in breast cancer''' | '''Table 3 - Genes with known hereditary risk associations in breast cancer''' Table derived from Geiersbach et al., 2018 [<nowiki>PMID 32087595</nowiki>] with permission from Cancer Genetics. | ||
{| class="wikitable" | {| class="wikitable" | ||
|'''Gene''' | |'''Gene''' | ||